<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/07CA7C33-3C80-4418-8B2A-A0B3A3B07DE4"><gtr:id>07CA7C33-3C80-4418-8B2A-A0B3A3B07DE4</gtr:id><gtr:firstName>Henry</gtr:firstName><gtr:surname>Jabbour</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127684438"><gtr:id>9152F7CD-7217-4458-85E6-FE7D13876B9C</gtr:id><gtr:title>Prostaglandin signalling and function in uterine physiology and pathology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127684438</gtr:grantReference><gtr:abstractText>Prostaglandins are molecules that are produced in the reproductive tract. They act locally by interacting with their receptors and are known to be important in proper functioning of the womb. Our research has shown that many of these molecules and their receptors are increased in many diseases/disorders of the womb. This programme is focused on understanding what prostaglandin receptors do in the womb and its pathologies including cancer. This is being investigated by unravelling the pathways and genes that are activated by specific prostaglandin receptors. In addition, the effect of these molecules and the genes they activate on changes in cell behaviour such as development of new blood vessels and changes in the function of immune cells is being assessed by using in vitro and in vivo model systems that are well adapted in our Centre. The potential inhibition of these effects by blocking the activity of the receptors or the signals they send inside the cell will also be assessed. Ultimately, it is envisaged that this research programme may lead to the development of new therapies in the treatment of pathologies of the reproductive tract that are associated with elevated expression of prostanoid receptors.</gtr:abstractText><gtr:technicalSummary>Prostaglandins are lipid mediators which are synthesized from arachidonic acid by the sequential action of several enzymes including a cyclooxygenase enzyme (COX-1 or COX-2) and a specific prostaglandin synthase enzyme. Prostaglandins mediate their effects in target cells following binding to their G-Protein Coupled Receptors (GPCR). COX enzymes and their prostaglandin lipid products are important regulators of normal endometrial processes which include menstruation, implantation and onset of labour. Our group and others have also shown that the synthesis and action of prostaglandins is dysregulated in a number of benign reproductive tract pathologies and disorders (such as heavy menstrual blood loss, dysmenorrhea and endometriosis) and cancer. My research programme aims to elucidate the role of prostaglandins and specific prostaglandin receptors in endometrial function and its pathologies. Over the past decade, a role has been established for COX enzymes and prostaglandins in mediating inflammatory events in many diseases including chronic inflammatory diseases, allergy and asthma, atherosclerosis, and metabolic and degenerative diseases. These inflammatory events involve alterations to the vascular and immune systems. Hence, my research focuses on delineating the role of specific prostaglandin receptors in mediating and altering inflammatory events. It is well recognized now that normal endometrial processes (such as menstruation and implantation) display hallmark signs of inflammation. Moreover, dysregulated and exacerbated onset of inflammatory processes may contribute to the initiation and progression of benign reproductive tract pathologies/disorders (such as menstrual disorders, endometriosis) and cancer. Non steroidal anti-inflammatory drugs (NSAID) that inhibit the activity of COX enzymes (namely the COX-2 inducible form) showed promise in suppressing inflammation. However, these drugs negatively impact on fertility in humans and are associated with increased risk of cardiovascular events, an effect attributed to the non-selective inhibition of synthesis of all prostaglandins even those with known beneficial roles such as prostacyclin by NSAID. Hence, it has been suggested that alternative therapies that inhibit the synthesis (drugs that target specific prostaglandin synthase enzymes) or signalling (drugs that target prostaglandin receptors) of specific prostaglandins may prove more useful therapeutically with little or no side effects.||Our research to-date has highlighted that activation of several prostaglandin receptors (such as EP and FP receptors) initiate inflammatory pathways. Moreover, in vitro and in vivo studies have highlighted that these receptors can regulate vascular and immune cell functions both are hallmarks of inflammatory events in the body.||Ultimately, this proposal may outline novel therapeutic intervention strategies to block the adverse effects of key prostaglandin receptor function and signalling in the various pathologies named above.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>5236678</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>71A4B6D6-60B7-46C1-A344-E64B66F3E61E</gtr:id><gtr:title>Prostaglandin receptor signalling and function in human endometrial pathology.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de6ad5c67e46aaa01f482d811e57ad1"><gtr:id>9de6ad5c67e46aaa01f482d811e57ad1</gtr:id><gtr:otherNames>Jabbour HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>pm_540e184e18455accc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8912B1C3-ED48-4ADC-B6F5-4C35620C05A3</gtr:id><gtr:title>Hypoxia-inducible factor-1alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2).</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ac0ac01fefa232a40f71da161f84a24"><gtr:id>4ac0ac01fefa232a40f71da161f84a24</gtr:id><gtr:otherNames>Critchley HO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>9360C22FC64</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F42880A-0642-4DF9-9403-D91A1C7C9C47</gtr:id><gtr:title>F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>61C36318C94</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEA3B2E0-1ADB-439E-8326-83C9686B981A</gtr:id><gtr:title>Endocrine regulation of menstruation.</gtr:title><gtr:parentPublicationTitle>Endocrine reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de6ad5c67e46aaa01f482d811e57ad1"><gtr:id>9de6ad5c67e46aaa01f482d811e57ad1</gtr:id><gtr:otherNames>Jabbour HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0163-769X</gtr:issn><gtr:outcomeId>AA1268B8F7F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBC28DAB-927D-4222-B915-5EED2056A0A5</gtr:id><gtr:title>Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathway.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_540e184e1845e7924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>381F68BC-96E4-4300-BAF9-4EC46796FCCD</gtr:id><gtr:title>Inflammatory events in endometrial adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31f367536cbfd03dee4bedee0b18ee30"><gtr:id>31f367536cbfd03dee4bedee0b18ee30</gtr:id><gtr:otherNames>Wallace AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>RrzTRerbozX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59F5BFC8-FA32-491E-BA06-798457155D14</gtr:id><gtr:title>Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de6ad5c67e46aaa01f482d811e57ad1"><gtr:id>9de6ad5c67e46aaa01f482d811e57ad1</gtr:id><gtr:otherNames>Jabbour HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>pm_540e183e183c6530c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1043148F-1F11-455B-8AE5-FE9D40073115</gtr:id><gtr:title>F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>DCCE0D455D5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B364C21-FCF3-42A5-A026-16AB64CA8356</gtr:id><gtr:title>Prostacyclin receptor up-regulates the expression of angiogenic genes in human endometrium via cross talk with epidermal growth factor Receptor and the extracellular signaling receptor kinase 1/2 pathway.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/895614482e5f96058ca46f613fe126d6"><gtr:id>895614482e5f96058ca46f613fe126d6</gtr:id><gtr:otherNames>Smith OP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>366CED1A16C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81CAF1F3-11E0-47B9-8D29-0E1F06CEAE6C</gtr:id><gtr:title>Estradiol-17beta, prostaglandin E2 (PGE2), and the PGE2 receptor are involved in PGE2 positive feedback loop in the porcine endometrium.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38cd547d67d6b02ef4c8bdbd0efeb0db"><gtr:id>38cd547d67d6b02ef4c8bdbd0efeb0db</gtr:id><gtr:otherNames>Waclawik A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>14E2C096A21</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C40FCC8C-C2F8-4C48-A7DC-C42C963CDF54</gtr:id><gtr:title>Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_540e184e1843096f8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46DFD83C-CFDC-4707-B658-558F5AB614E2</gtr:id><gtr:title>Autocrine/paracrine regulation of apoptosis in epithelial cells by prostaglandin E2.</gtr:title><gtr:parentPublicationTitle>Prostaglandins, leukotrienes, and essential fatty acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de6ad5c67e46aaa01f482d811e57ad1"><gtr:id>9de6ad5c67e46aaa01f482d811e57ad1</gtr:id><gtr:otherNames>Jabbour HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0952-3278</gtr:issn><gtr:outcomeId>pm_540e183e183e5cb77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DBB6D2E-07B4-48B0-AE43-292FD97DD912</gtr:id><gtr:title>Seminal plasma promotes the expression of tumorigenic and angiogenic genes in cervical adenocarcinoma cells via the E-series prostanoid 4 receptor.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/073cc6a624ca86f3c698cdaf76feb3eb"><gtr:id>073cc6a624ca86f3c698cdaf76feb3eb</gtr:id><gtr:otherNames>Muller M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>0141CF207F0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F460F58F-7261-4DF7-8319-8C0617C3FB69</gtr:id><gtr:title>Inflammatory pathways in female reproductive health and disease.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de6ad5c67e46aaa01f482d811e57ad1"><gtr:id>9de6ad5c67e46aaa01f482d811e57ad1</gtr:id><gtr:otherNames>Jabbour HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>A32E7E156FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22194B1D-8380-4D13-944D-CFF4EA63FABB</gtr:id><gtr:title>Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_540e183e183b37220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA49AA0E-003E-40BD-A2CE-F78EE606B204</gtr:id><gtr:title>Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5ffd72b236fbe6ee7377050866da0cf"><gtr:id>b5ffd72b236fbe6ee7377050866da0cf</gtr:id><gtr:otherNames>Evans J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>7322A7E05EC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05963375-79A5-4656-B510-F00703874605</gtr:id><gtr:title>Cyclooxygenase-2 overexpression inhibits cathepsin D-mediated cleavage of plasminogen to the potent antiangiogenic factor angiostatin.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c34fea1fc0d224c11b0b69d7f0c990d8"><gtr:id>c34fea1fc0d224c11b0b69d7f0c990d8</gtr:id><gtr:otherNames>Perchick GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_540e184e1840591d7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78ACC4EE-C338-450F-8524-66FE637BAFC4</gtr:id><gtr:title>Chemokine (C-C) motif ligand 20 is regulated by PGF(2a)-F-prostanoid receptor signalling in endometrial adenocarcinoma and promotes cell proliferation.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31f367536cbfd03dee4bedee0b18ee30"><gtr:id>31f367536cbfd03dee4bedee0b18ee30</gtr:id><gtr:otherNames>Wallace AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>D5vSkDHhSCk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04105C88-2AB9-4A7B-A992-BA2005826D40</gtr:id><gtr:title>Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee7a300117df7cff80b0ee7db93602ca"><gtr:id>ee7a300117df7cff80b0ee7db93602ca</gtr:id><gtr:otherNames>Catalano RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>60B6F3AE_E60B6F3AE_E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1163468E-4FB2-4DA1-A5C1-FAC80D6FFA17</gtr:id><gtr:title>Comprehensive expression analysis of prostanoid enzymes and receptors in the human endometrium across the menstrual cycle.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee7a300117df7cff80b0ee7db93602ca"><gtr:id>ee7a300117df7cff80b0ee7db93602ca</gtr:id><gtr:otherNames>Catalano RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>1420EBC9_D1420EBC9_D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9788E99D-3CC1-4605-86D2-23773D45BDDA</gtr:id><gtr:title>Prostaglandin (PG) F(2alpha) receptor expression and signaling in human endometrium: role of PGF(2alpha) in epithelial cell proliferation.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f8cab96d43eda5b926336d99bacac7f"><gtr:id>2f8cab96d43eda5b926336d99bacac7f</gtr:id><gtr:otherNames>Milne SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_540e183e183fab3ab</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDD1D09D-341D-4784-BA34-701E3F29171B</gtr:id><gtr:title>Prostaglandin E2 as a regulator of germ cells during ovarian development.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58f604c071ae6689a7e6c93ebd79b111"><gtr:id>58f604c071ae6689a7e6c93ebd79b111</gtr:id><gtr:otherNames>Bayne RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>7CA22C622B7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9709F3AB-9282-44F4-B944-7B562C1563ED</gtr:id><gtr:title>Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/895614482e5f96058ca46f613fe126d6"><gtr:id>895614482e5f96058ca46f613fe126d6</gtr:id><gtr:otherNames>Smith OP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>5F9A26D704F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF6E4E0D-DC9D-4B4B-8A34-0F02F9A24FFD</gtr:id><gtr:title>Prostaglandin E2 induces proliferation of glandular epithelial cells of the human endometrium via extracellular regulated kinase 1/2-mediated pathway.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de6ad5c67e46aaa01f482d811e57ad1"><gtr:id>9de6ad5c67e46aaa01f482d811e57ad1</gtr:id><gtr:otherNames>Jabbour HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_540e184e1841022f5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34A9E3C0-7512-4B76-88F8-EA22FBCFBC3D</gtr:id><gtr:title>Prokineticin-1 (PROK1) modulates interleukin (IL)-11 expression via prokineticin receptor 1 (PROKR1) and the calcineurin/NFAT signalling pathway.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73bdba59d373cafc57c83d644dd33398"><gtr:id>73bdba59d373cafc57c83d644dd33398</gtr:id><gtr:otherNames>Cook IH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>655CBD2DF27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2E0AFDE-0772-4485-B901-73FC276C368C</gtr:id><gtr:title>Reciprocal cross talk between gonadotropin-releasing hormone (GnRH) and prostaglandin receptors regulates GnRH receptor expression and differential gonadotropin secretion.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffe7a2d34916a6fc5789de16c4c3a085"><gtr:id>ffe7a2d34916a6fc5789de16c4c3a085</gtr:id><gtr:otherNames>Naor Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>FA39B921161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3C7F15D-8D0A-4D6B-9D61-9E6FA183C691</gtr:id><gtr:title>Prostaglandin receptors are mediators of vascular function in endometrial pathologies.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de6ad5c67e46aaa01f482d811e57ad1"><gtr:id>9de6ad5c67e46aaa01f482d811e57ad1</gtr:id><gtr:otherNames>Jabbour HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>EE7F76F4828</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23CFA0AF-64B4-48AA-B064-21CA7E6D90D3</gtr:id><gtr:title>Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c207638d604c4fe306c0028d12dd38a5"><gtr:id>c207638d604c4fe306c0028d12dd38a5</gtr:id><gtr:otherNames>Battersby S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>pm_540e184e1844a623a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF3FEF38-F620-4F7F-BE0C-2F0D05C2C04C</gtr:id><gtr:title>Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>0933841C8F3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50D334CD-5212-465C-BCC1-A8AFFC27BA86</gtr:id><gtr:title>Chlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and NF?B activation resulting in a microenvironment predisposed to ectopic pregnancy.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14de62df5421087cc23fb4b70ab4e55f"><gtr:id>14de62df5421087cc23fb4b70ab4e55f</gtr:id><gtr:otherNames>Shaw JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>ABE14B74_EABE14B74_E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA0084D3-6D68-4716-8EEB-96101A1144B8</gtr:id><gtr:title>Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94335aa40ba3df2a38b38cee8bab482a"><gtr:id>94335aa40ba3df2a38b38cee8bab482a</gtr:id><gtr:otherNames>Maldonado-P?rez D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>4163FA06264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3A1F5DC-CB9E-48B6-837F-13ADCD59D265</gtr:id><gtr:title>Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>pm_540e184e18426d5a0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D1B89A8-5421-43D4-8531-D79E8BB35E66</gtr:id><gtr:title>A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>bNer3HRW6Bp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39ED7ADC-B709-4446-98DB-50D9A21C5F4A</gtr:id><gtr:title>Endocrine immune interactions in human parturition.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27ff6ca20433b9c6e7e04ae514b5a55c"><gtr:id>27ff6ca20433b9c6e7e04ae514b5a55c</gtr:id><gtr:otherNames>Golightly E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>riCEpDFgSBp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD33E8E1-161A-49C7-9BF3-39E3FC0D82E5</gtr:id><gtr:title>Prokineticin 1 signaling and gene regulation in early human pregnancy.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5ffd72b236fbe6ee7377050866da0cf"><gtr:id>b5ffd72b236fbe6ee7377050866da0cf</gtr:id><gtr:otherNames>Evans J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>FABDEBC5BB7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8534C93E-4929-4BF3-A23C-B6C088DB0AB6</gtr:id><gtr:title>Chorionic gonadotrophin regulates CXCR4 expression in human endometrium via E-series prostanoid receptor 2 signalling to PI3K-ERK1/2: implications for fetal-maternal crosstalk for embryo implantation.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>DBE5A852_3DBE5A852_3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10907033-9D78-4965-89BC-12EBFF8B899E</gtr:id><gtr:title>Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c207638d604c4fe306c0028d12dd38a5"><gtr:id>c207638d604c4fe306c0028d12dd38a5</gtr:id><gtr:otherNames>Battersby S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>C5608C2AC49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34E85F04-B111-4D1F-B9DD-109ADCE049EC</gtr:id><gtr:title>Potential roles of the prokineticins in reproduction.</gtr:title><gtr:parentPublicationTitle>Trends in endocrinology and metabolism: TEM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94335aa40ba3df2a38b38cee8bab482a"><gtr:id>94335aa40ba3df2a38b38cee8bab482a</gtr:id><gtr:otherNames>Maldonado-P?rez D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1043-2760</gtr:issn><gtr:outcomeId>24A976DA311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAD2370F-6923-449A-8F8E-30A2F663E1E1</gtr:id><gtr:title>Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>pm_540e183e183d1da3a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC148977-D270-433D-BCAB-0C89770D8996</gtr:id><gtr:title>Cotinine exposure increases Fallopian tube PROKR1 expression via nicotinic AChRalpha-7: a potential mechanism explaining the link between smoking and tubal ectopic pregnancy.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14de62df5421087cc23fb4b70ab4e55f"><gtr:id>14de62df5421087cc23fb4b70ab4e55f</gtr:id><gtr:otherNames>Shaw JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>nSiqMdCKwUB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9026949C-53B9-4F94-B897-8FE0CB19FBCD</gtr:id><gtr:title>A role for lipoxin A4 as anti-inflammatory and proresolution mediator in human parturition.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94335aa40ba3df2a38b38cee8bab482a"><gtr:id>94335aa40ba3df2a38b38cee8bab482a</gtr:id><gtr:otherNames>Maldonado-P?rez D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>KZxb1n4BFRH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54FE1864-48BB-426C-92CB-4DA2752C51B5</gtr:id><gtr:title>Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>209DE806CD0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9683315-F8F3-405A-9161-59478E3F5AD2</gtr:id><gtr:title>Expression and localization of endothelial monocyte-activating polypeptide II in the human endometrium across the menstrual cycle: regulation of expression by prostaglandin E(2).</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c207638d604c4fe306c0028d12dd38a5"><gtr:id>c207638d604c4fe306c0028d12dd38a5</gtr:id><gtr:otherNames>Battersby S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_540e183e183db4a2e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>488E8EA3-6D7A-42C9-81A1-287388F10BC2</gtr:id><gtr:title>Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51a99fc6df4b1bc571b326623aba53e9"><gtr:id>51a99fc6df4b1bc571b326623aba53e9</gtr:id><gtr:otherNames>Denison FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>D1E3B4F343B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CCD9803-CCFB-4B22-B469-2890F4465D2D</gtr:id><gtr:title>Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31f367536cbfd03dee4bedee0b18ee30"><gtr:id>31f367536cbfd03dee4bedee0b18ee30</gtr:id><gtr:otherNames>Wallace AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>D71F0C13603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A96207FB-6472-4530-BA91-3AA843410D05</gtr:id><gtr:title>Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.</gtr:title><gtr:parentPublicationTitle>BMC cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b432a0e25bf93636fc88c46b62632c61"><gtr:id>b432a0e25bf93636fc88c46b62632c61</gtr:id><gtr:otherNames>Collins F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2407</gtr:issn><gtr:outcomeId>3BFC88C8A10</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54FE9E62-DE31-4AB2-BE20-358805CD19CB</gtr:id><gtr:title>A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de6ad5c67e46aaa01f482d811e57ad1"><gtr:id>9de6ad5c67e46aaa01f482d811e57ad1</gtr:id><gtr:otherNames>Jabbour HN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_540e184e1846c48ba</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92003724-D808-4449-963F-41944AEECE58</gtr:id><gtr:title>Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>XshF4SFMr4T</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09BB313A-EF3B-4C34-A0AC-409A9FCB34D0</gtr:id><gtr:title>Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>pm_540e183e183f089ef</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4B569AE-5A18-431A-A70A-4ECA8560FC79</gtr:id><gtr:title>Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7c86e61ebba2b16f526ad94812c25cd"><gtr:id>d7c86e61ebba2b16f526ad94812c25cd</gtr:id><gtr:otherNames>Qualtrough D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>BF958DF0DA2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3720A8CA-CB72-4CEF-8A7E-6672084E8544</gtr:id><gtr:title>Expression, localization, and signaling of PGE(2) and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f8cab96d43eda5b926336d99bacac7f"><gtr:id>2f8cab96d43eda5b926336d99bacac7f</gtr:id><gtr:otherNames>Milne SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2001-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_540e183e183bca6f6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A5761A2-4727-40B3-B718-59E28C1624D5</gtr:id><gtr:title>Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>pm_540e184e1843c6434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>131CF515-94E9-4139-978B-7E66BED22512</gtr:id><gtr:title>EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway.</gtr:title><gtr:parentPublicationTitle>Cellular signalling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29372e9f942a07968e30ca57241473f1"><gtr:id>29372e9f942a07968e30ca57241473f1</gtr:id><gtr:otherNames>Abera AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0898-6568</gtr:issn><gtr:outcomeId>DC29E963E54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55299F1A-4147-452F-8FD7-50BBF31ABBC1</gtr:id><gtr:title>F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2.</gtr:title><gtr:parentPublicationTitle>BMC cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2329b5f4f44df2c7ba64c74f57dad30"><gtr:id>e2329b5f4f44df2c7ba64c74f57dad30</gtr:id><gtr:otherNames>Keightley MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2121</gtr:issn><gtr:outcomeId>E9510C14D8D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75895FED-6430-455C-859F-54052C0CD940</gtr:id><gtr:title>Inflammatory pathways in endometrial disorders.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14661cfcf1a005e8090117ba86348d2c"><gtr:id>14661cfcf1a005e8090117ba86348d2c</gtr:id><gtr:otherNames>Maybin JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>UQTSt5ZybRR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8B8EBC4-9297-4D87-8073-53F2D95F6C00</gtr:id><gtr:title>Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology.</gtr:title><gtr:parentPublicationTitle>Prostaglandins &amp; other lipid mediators</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ec43acd3666ecf58578b07a8d18fb9"><gtr:id>85ec43acd3666ecf58578b07a8d18fb9</gtr:id><gtr:otherNames>Sales KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1098-8823</gtr:issn><gtr:outcomeId>pm_540e184e1841bb2b4</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127684438</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>